DNLI Dividend History & Analysis | N/A Yield

DNLI has a dividend yield of N/A and paid N/A per share in the last 12M. Complete payout history, full analyses and peer comparison.

As of November 2025, Denali Therapeutics (DNLI) does not pay a dividend.

Top Dividend Payers in Biotechnology

Top 5 Dividend Yields of Peer-Group
Symbol Market Cap (USD) Dividend Yield TTM Yield on Cost (purchase 5y ago)
JBIO 280 M 26.1% 0.31%
ABBV 403,129 M 2.99% 8.38%
GILD 152,766 M 2.64% 6.47%
AMGN 157,202 M 2.93% 4.68%
HLN 41,279 M 1.86% 2.46%
Top 5 Dividend Growth Rates of Peer-Group
Symbol Market Cap (USD) Growth Rate (CAGR) Payout Consistency
GRFS 7,481 M 127% 60.7%
HLN 41,279 M 51.0% 100%
AMGN 157,202 M 8.90% 100%
ABBV 403,129 M 7.06% 100%
GILD 152,766 M 3.16% 100%

Similar Stocks with Attractive Dividends - Compare DNLI Dividends with its Peer-Group

ABBV
AbbVie
2.99% Yield
AMGN
Amgen
2.93% Yield
GILD
Gilead Sciences
2.64% Yield
HLN
Haleon
1.86% Yield

DNLI Dividend History: as of November 2025

No dividends paid yet.

DNLI Dividend FAQ

Denali Therapeutics Inc (NASDAQ:DNLI) is a biotechnology company listed on the NASDAQ stock exchange, operating in the biotechnology sub-industry. The companys stock is classified as a common stock and is of US origin.

What is the Dividend Yield of DNLI?

As of November 2025, DNLI`s dividend yield is %. This is calculated by dividing the trailing 12-month dividend rate (TTM rate) of - by the current share price of 15.02.

Does DNLI pay a dividend?

As of November 2025 DNLI does not pay a dividend.

How often does DNLI pay dividends?

Over the last 12 months, DNLI has issued dividend payments.

Will DNLI pay dividends in 2025?

The next Ex-Dividend date for Denali Therapeutics (DNLI) is currently unknown.

What is the next Ex-Dividend Date for DNLI?

The next Ex-Dividend date for Denali Therapeutics (DNLI) is currently unknown. We automatically update the next Ex-Dividend date when it is announced.

What is the Dividend Growth of DNLI?

DNLI's average dividend growth rate over the past 5 years is -% per year.

What is the Yield on Cost of DNLI?

DNLI's 5-Year Yield on Cost is -%. If you bought DNLI's shares at 55.81 five years ago, your current annual dividend income (- per share, trailing 12 months) equals -% of your original purchase price.

What is the Payout Consistency of DNLI?

DNLI Payout Consistency is 0.0%. The payout consistency is a proprietary measure of how consistently a company has paid dividends over its lifetime and blends growth rate, number of dividend payments, interruptions or lowering dividends into one number.

Does DNLI have a good Dividend Yield?

DNLI`s % Dividend Yield is considered as unknown.

What is the Dividend Payout Ratio of DNLI?

The Dividend Payout Ratio of DNLI is unknown.

What is the Dividend Rating of DNLI?

DNLI`s Overall Dividend Rating is (unknown). Ratings surpassing 65% are regarded as acceptable, exceeding 75% are favorable and surpassing 85% are strong.

DNLI Outstanding Shares Analysis

What is the Trend in DNLI`s Outstanding Shares (CAGR)?

Denali Therapeutics`s outstanding shares have increased by approximately 14.09% annually over the past 3 years (Correlation: 100.0%), negatively influencing the share price.

Has Denali Therapeutics ever had a Stock Split?

No Stock Splits found.
Year Number of Shares Annual Growth Rate
2015 3,000,000
2016 6,000,000 +100%
2017 15,000,000 +150%
2018 93,000,000 +520%
2019 96,000,000 +3.23%
2020 113,000,000 +17.71%
2021 122,000,000 +7.96%
2022 126,000,000 +3.28%
2023 137,000,000 +8.73%
2024 164,000,000 +19.71%

Key Metric Definitions

  • Dividend Yield: Annual dividend per share divided by current share price.
  • Dividend Growth Rate: Compound annual growth rate of annual dividend per share over the last 5 years.
  • Payout Ratio: Percentage of earnings paid as dividends (TTM).
  • Payout Consistency: % of eligible periods with uninterrupted or increased dividends, measured over the entire lifetime of the stock or fund.
  • Payout Frequency: Number of dividends paid in the last 12m (TTM).
  • Overall Dividend Rating: Proprietary composite score, quantified on a scale from 0 to +100. Ratings surpassing 70 are regarded as favorable, while those exceeding 85 are strong.
  • Total Return: Price appreciation plus dividends over specified period.
  • Market Cap: Figures are in millions of the corresponding currency.

Last update: 2025-10-27 02:03